Abstract:Glioblastomas (GBMs) are dreadful brain tumors with abysmal survival outcomes. GBM EVs dramatically affect normal brain cells (largely astrocytes) constituting the tumor microenvironment (TME). EVs from different patient-derived GBM spheroids induced differential transcriptomic, secretomic, and proteomic effects on cultured astrocytes/brain tissue slices as GBM EV recipients. The net outcome of brain cell differential changes nonetheless converges on increased tumorigenicity. GBM spheroids and brain slices were derived from neurosurgical patient tissues following informed consent. Astrocytes were commercially obtained. EVs were isolated from conditioned culture media by ultrafiltration, ultraconcentration, and ultracentrifugation. EVs were characterized by nanoparticle tracking analysis, electron microscopy, biochemical markers, and proteomics. Astrocytes/brain tissues were treated with GBM EVs before downstream analyses. EVs from different GBMs induced brain cells to alter secretomes with pro-inflammatory or TME-modifying (proteolytic) effects. Astrocyte responses ranged from anti-viral gene/protein expression and cytokine release to altered extracellular signal-regulated protein kinase (ERK1/2) signaling pathways, and conditioned media from EV-treated cells increased GBM cell proliferation. Thus, astrocytes/brain slices treated with different GBM EVs underwent non-identical changes in various ‘omics readouts and other assays, indicating “personalized” tumor-specific GBM EV effects on the TME. This raises concern regarding reliance on “model” systems as a sole basis for translational direction. Nonetheless, net downstream impacts from differential cellular and TME effects still led to increased tumorigenic capacities for the different GBMs.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the impact of glioblastoma (GBMs) extracellular vesicles (EVs) on normal human brain cells (mainly astrocytes). Specifically, the researchers are concerned with how EVs from GBM spheroids from different patient sources cause differential effects on astrocytes / brain tissue slices in terms of transcriptomics, secretomics and proteomics, and how these changes ultimately converge into results that increase tumorigenicity. ### Research Background and Problems Glioblastoma is an extremely deadly brain tumor. The survival time of patients is usually only 15 - 16 months, and almost no one can escape. Although there have been many advances in genetic variation, target identification, new treatment modalities and immunotherapy, the improvement in patient survival has been limited since the introduction of temozolomide combined with radiotherapy as the standard treatment in 2005. Therefore, a better understanding of tumor biology may contribute to the development of more effective treatment methods. This article specifically focuses on the role of GBM exosomes in regulating the tumor microenvironment (TME) and explores how they promote tumor development by affecting normal brain cells. ### Research Methods - **Sample Acquisition**: GBM spheroids were cultured from tumor samples collected during neurosurgery, and astrocytes were extracted from normal brain tissue obtained during epilepsy surgery. - **Exosome Isolation and Characterization**: EVs were isolated from conditioned medium by methods such as differential centrifugation, ultrafiltration concentration and ultra - centrifugation, and characterized using techniques such as nanoparticle tracking analysis, electron microscopy, biochemical markers and proteomics. - **Cell Treatment and Downstream Analysis**: After astrocytes / brain tissue slices were treated with GBM EVs, analyses such as transcriptomics, proteomics, secretomics, proliferation assays, phosphorylation signal arrays and protease activity assays were carried out. ### Main Findings - **Differential Effects**: EVs from different GBM spheroids induce different transcriptomic, secretomic and proteomic changes in astrocytes. Although these changes are different, they all ultimately lead to an increase in tumorigenicity. - **Virus - like Response**: EVs from F3 - 8 GBM cells induce changes in astrocytes similar to a viral response, while EVs from G17 - 1 GBM cells mainly affect the extracellular space of astrocytes. - **Functional Impact**: The conditioned medium of astrocytes treated with EVs can increase the proliferation of GBM cells, indicating that EVs promote tumor growth by changing the functional state of astrocytes. ### Conclusions The research results emphasize the individualized impact of GBM exosomes on normal brain cells in the tumor microenvironment, suggesting caution in the development of treatment methods based on a single tumor model. In addition, the study also shows that true precision medicine may require a comprehensive analysis of the tumor, its exosomes and their impact on different cell types.

A tale of two tumors: differential, but detrimental, effects of glioblastoma extracellular vesicles (EVs) on normal human brain cells

Abstract 2776: Exploring the differences between brain tumor initiating cell extracellular vesicles and secreted factors that influence the tumor microenvironment

Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?

Exploring Extracellular Vesicle Surface Protein Markers Produced by Glioblastoma Tumors: A Characterization Study Using In Vitro 3D Patient-Derived Cultures

Extracellular Vesicles in Brain Tumor Progression

Role of Tumor-Derived Extracellular Vesicles in Glioblastoma

Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment

Abstract 2130: Glioblastoma-derived extracellular vesicle cargo as a reporter of drug delivery and effect

Interplay Between V-ATPase G1 and Small EV-miRNAs Modulates ERK1/2 Activation in GBM Stem Cells and Nonneoplastic Milieu

The Detrimental Effects of Extrinsic Reinforcement on “Intrinsic Motivation”

[Statistical observations on the importance of ear forms in determination of hereditary & biological descent].

305 Extracellular Vesicular mRNA and miRNA Biomarkers in Patients With Glioblastoma

Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression

A detailed evaluation of the advantages among extracellular vesicles from three cell origins for targeting delivery of celastrol and treatment of glioblastoma

BIOM-10. CIRCULATING EXTRACELLULAR VESICLES AS A TOOL FOR DIAGNOSIS, PROGNOSIS AND MONITORING IN GLIOMA

Extracellular vesicles produced by irradiated endothelial or Glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment

Correction: The Avian Head Induces Cues for Sound Localization in Elevation

SDPS-31 EXTRACELLULAR VESICLES AND THEIR CARGO AS A PHARMACODYNAMIC REPORTER IN GLIOBLASTOMA

Large and small extracellular vesicles released by glioma cells in vitro and in vivo

Biom-21. Small Extracellular Vesicles As A Novel Liquid Biopsy Approach For Glioblastoma

Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions